Skip to main content
Signal8

Pena Luis C.

SEC insider (Form 3/4/5 filer). CIK 0001620548. President & CEO at Evommune, Inc. (EVMN). 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in PALO ALTO, CA.

Companies Pena Luis C. has filed insider reports for

  • Evommune, Inc. (EVMN): Director, Officer, President & CEO
Pena Luis C. profile photo

Pena Luis C.

CIK: 0001620548

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Evommune, Inc. logo
EVMN

Evommune, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Sep 30, 2026
    Award
    Direct
    1.1K shares at avg. $7.02$8K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Jun 22, 2026
    Sale
    Direct
    7.4K shares at avg. $22.71$169K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Jun 1, 2026
    Sale
    Direct
    16.8K shares at avg. $22.74$382K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Apr 16, 2026
    Award

    Employee Stock Option (Right to Buy)

    Direct
    291.4K shares-
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Dec 9, 2025
    Tax Payment
    Direct
    28.1K shares at avg. $17.84$502K
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Nov 7, 2025
    Conversion
    Direct
    24.2K shares-
  • Evommune, Inc. logo
    EVMN

    Evommune, Inc.

    Nov 5, 2025
    Award

    Employee Stock Option (Right to Buy)

    Direct
    796.8K shares-

1-7 of 7